TKSoftware Inc. today launches ICONIC Pro, a unified, cloud–based platform that combines claims submission, electronic remittance, eligibility verification, and claims scrubbing—designed to simplify revenue cycle management for healthcare providers of all sizes.
CARMEL, Ind., June 23, 2025 /PRNewswire/ — TKSoftware Inc., a leader in medical billing and practice management solutions, has introduced ICONIC Pro, its next–generation all–in–one medical billing and clearinghouse platform. Built on a scalable cloud architecture, ICONIC Pro streamlines the end–to–end revenue cycle—from real–time eligibility checks to automated denial management—empowering medical practices to reduce administrative overhead and accelerate reimbursements.
“With ICONIC Pro, we’re redefining efficiency in healthcare billing. By unifying core clearinghouse functions into one intuitive interface, providers can focus on patient care, not claim paperwork,” said Tony Kurzendoerfer, President and Chief Engineer at TKSoftware Inc.
Key Features of ICONIC Pro:
Who Benefits:
Why ICONIC Pro Stands Out:
Unlike siloed billing tools, ICONIC Pro integrates clearinghouse, analytics, and denial management in a single SaaS solution—eliminating multiple vendor contracts and disparate interfaces. Its cloud–native design delivers automatic updates and 99.9% uptime, backed by TKSoftware’s responsive support team.
About TKSoftware Inc.:
TKSoftware Inc. is an Indiana–based technology company specializing in medical billing, practice management, and clearinghouse solutions. For over 25 years, TKSoftware has empowered healthcare providers with innovative, compliant, and user–friendly platforms that optimize revenue cycle performance and improve patient satisfaction.
Learn More:
Visit tksoftwareinc.com to schedule a demo and discover how ICONIC Pro can transform your practice’s revenue cycle management.
Contact:
Tony Kurzendoerfer
info@tksoftwareinc.com
13172280857
Photos:
https://www.prlog.org/13083737
Press release distributed by PRLog
SOURCE TKSoftware Inc.
New multilingual capabilities expand access to real-time GLP-1 dining guidance as WHO highlights the importance…
ATLANTA, GA AND DOHA, QATAR / ACCESS Newswire / December 6, 2025 / Ameerex Corporation…
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
– Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial…
SPRING, Texas, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical…
Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates consistent overall response rate and safety…